News
XFLT Strongly Beats Loan And Bond Funds, Yields 15% (NYSE:XFLT)
This article was written byFollowRida Morwa is a former investment and commercial Banker, with over 35 years of experience. He…
Editor's Top Picks
Donald Trump’s election nemesis returns to help protect the vote in Georgia
Brad Raffensperger is all too familiar with attempts to subvert US democracy.The Secretary of State for Georgia was on the…
Your one-stop resource for personal news and tips.
More form News
Servicing The Federal Debt | Seeking Alpha
This article was written byB.A., M.A., University of Pennsylvania,; M.A., (Oxon.); Ph.D. Princeton University Currently…
Thames Water falls short of £1bn goal with £750mn injection
Receive free Thames Water PLC updatesWe’ll send you a myFT Daily Digest email rounding up…
Bank of America: Still Undervalued After Dividend Increase (NYSE:BAC)
I recently profiled JPMorgan Chase & Co.'s (JPM) dividend increase and the underlying strength of…
European stocks slip after data shows China on brink of deflation
Receive free Markets updatesWe’ll send you a myFT Daily Digest email rounding up the latest…
Sea Stock: This Is The Time To Make A Big Splashy Bet (NYSE:SE)
With the S&P 500 hovering around 12-month highs despite macro jitters, a common question investors…
Deutsche wins credit card deal for Lufthansa frequent-flyer scheme
Receive free Deutsche Bank AG updatesWe’ll send you a myFT Daily Digest email rounding up…
Colgate-Palmolive: Challenging Growth Prospects (NYSE:CL)
Amid stiff competition in a generally saturated market, American oral care giant Colgate-Palmolive (NYSE:CL) has…
China on brink of consumer deflation
Receive free Chinese economy updatesWe’ll send you a myFT Daily Digest email rounding up the…
Revenge Of The Mini-Me. Oracle, Rivian, And Advanced Micro – I Explain
These 3 are smaller than the competition, make no mistake they bring a lot to…
From TSMC to Samsung, Asia’s chipmakers struggle to go green
Insufficient access to renewable energy in their home markets has left Asia’s biggest chipmakers lagging…
Aldeyra (ALDX): Navigating The Future Of Eye Disease Treatment With Reproxalap
Introduction Aldeyra Therapeutics (NASDAQ:ALDX) is a biotech firm focused on creating therapies for immune-mediated diseases.…
Gautam Adani: the Indian billionaire vs the short seller
You can enable subtitles (captions) in the video player The story of Adani is the…
Biogen And Alzheimer’s Disease: Too Early To Celebrate (NASDAQ:BIIB)
On July 6, 2023, the Food and Drug Administration granted full approval to Biogen (NASDAQ:BIIB)…
SVB Financial sues US banking regulator to recover $1.9bn
Receive free SVB Financial Group updatesWe’ll send you a myFT Daily Digest email rounding up…
Eli Lilly: The Party Is Likely Over (NYSE:LLY)
Investors in Eli Lilly and Company (NYSE:LLY) have benefited from its solid execution in its…